ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT01218048 · COMPLETED
Trial details
- NCT number
- NCT01218048
- Sponsor
- Robert Ferris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2015-11-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.